Mónica Ferrando-Beltrán
Mónica Ferrando-Beltrán publishes mostly in Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, on topics such as Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research and Cardiovascular Function and Risk Factors.
- World rank
- #6,571,238 of 7,710,434 ranked researchers
- Rank in Spain
- #162,349 of 204,306
- Works
- 19
- Citations
- 58
- Citations per work
- 3.1
What does Mónica Ferrando-Beltrán research?
Mónica Ferrando-Beltrán's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1475.0%
- Medicine1475.0%
- Everything else419.6%
- Life Sciences15.4%
- 1Cardiology and Cardiovascular Medicine38% of their works
- 2Radiology, Nuclear Medicine and Imaging18% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Oncology7% of their works
- 5Molecular Biology5% of their works
- 6Internal Medicine4% of their works
Research topics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Venous Thromboembolism Diagnosis and Management
- Peptidase Inhibition and Analysis
- Inflammatory Biomarkers in Disease Prognosis
- Medical Imaging and Pathology Studies
Which keywords describe Mónica Ferrando-Beltrán's research?
The keywords of their largest research topics: Myocardial Infarction, Cardiac Imaging, Coronary Artery Disease, Acute Coronary Syndromes, ST-Segment Elevation, Chamber Quantification, Echocardiography and Diagnosis.
- Venous Thromboembolism
- Pulmonary Sclerosing Hemangioma
- Inflammation
- Fibroblast Activation Protein
- Cancer
- Tumor Microenvironment
- Diagnosis
- Chamber Quantification
- Acute Coronary Syndromes
- Cardiac Imaging
- Myocardial Infarction
- Coronary Artery Disease
- ST-Segment Elevation
- Echocardiography
- Treatment
- Antithrombotic Therapy
- Cardiac Amyloidosis
- Immunosuppression
- Pulmonary Alveolar Microlithiasis
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Myocardial Infarction162 topics
- Cardiac Imaging91 topic
- Coronary Artery Disease91 topic
- Acute Coronary Syndromes71 topic
- ST-Segment Elevation71 topic
- Chamber Quantification51 topic
- Echocardiography51 topic
- Diagnosis42 topics
- Treatment42 topics
- Tumor Microenvironment42 topics
- Antithrombotic Therapy21 topic
- Cancer21 topic
- Cardiac Amyloidosis21 topic
- Fibroblast Activation Protein21 topic
- Immunosuppression21 topic
- Inflammation21 topic
- Pulmonary Alveolar Microlithiasis21 topic
- Pulmonary Sclerosing Hemangioma21 topic
- Transthyretin21 topic
- Venous Thromboembolism21 topic
Where does Mónica Ferrando-Beltrán work?
Mónica Ferrando-Beltrán's main affiliation in the publication record is Hospital General Universitario De Valencia, Spain.
How many publications and citations does Mónica Ferrando-Beltrán have?
OpenAlex counts 19 works and 58 citations for Mónica Ferrando-Beltrán, an h-index of 4, ranking #6,571,238 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mónica Ferrando-Beltrán. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.